Development
Cardio Diagnostics Holdings, Inc.
CDIO
$4.77
$0.2455.42%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 11.11% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 11.11% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 11.11% | -- |
| SG&A Expenses | 23.35% | 226.24% | 608.75% | 861.01% | 1,017.99% |
| Depreciation & Amortization | 20.00% | 20.00% | 20.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.35% | 224.64% | 632.20% | 1,139.71% | 493.86% |
| Operating Income | -25.48% | -224.41% | -632.20% | -1,145.08% | -493.86% |
| Income Before Tax | -67.90% | -377.78% | -255.95% | -1,145.08% | -493.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -67.90% | -377.78% | -255.95% | -1,145.08% | -493.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.90% | -377.78% | -255.95% | -1,145.08% | -493.86% |
| EBIT | -25.48% | -224.41% | -632.20% | -1,145.08% | -493.86% |
| EBITDA | -22.42% | -225.45% | -642.91% | -1,169.57% | -504.27% |
| EPS Basic | 6.72% | -153.26% | -57.50% | -115.48% | -4.13% |
| Normalized Basic EPS | 1.29% | -146.47% | -96.51% | -115.36% | -4.21% |
| EPS Diluted | 6.72% | -153.26% | -57.50% | -115.48% | -4.13% |
| Normalized Diluted EPS | 1.29% | -146.47% | -96.51% | -115.36% | -4.21% |
| Average Basic Shares Outstanding | 79.98% | 88.72% | 126.05% | 477.99% | 470.42% |
| Average Diluted Shares Outstanding | 79.98% | 88.72% | 126.05% | 477.99% | 470.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |